Metraipolis › archive › dc_ed2cfa8cd53b

Anti-progestin therapy targets hallmarks of breast cancer risk — Europe PMC PMID:41193807

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41193807
DOI: 10.1038/s41586-[numero omesso]-7
License (as archived): solo-consultazione
Archived: 2026-11-08T19:10:56.050Z
SHA-256 of the archived text: 975052def4a02eeb3bd3e07e2d9606b9656a0e6dbc93699722b470c9dde6e1df
Stable URL of this page: https://metraipolis.com/documento/dc_ed2cfa8cd53b

How to cite

Anti-progestin therapy targets hallmarks of breast cancer risk — Europe PMC PMID:41193807 — Europe PMC (en), https://europepmc.org/article/MED/41193807 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ed2cfa8cd53b (Metraipolis archive dc_ed2cfa8cd53b, sha256 975052def4a02eeb3bd3e07e2d9606b9656a0e6dbc93699722b470c9dde6e1df)

BibTeX

@misc{dced2cfa8cd53b,
  title = {Anti-progestin therapy targets hallmarks of breast cancer risk — Europe PMC PMID:41193807},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41193807},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ed2cfa8cd53b; sha256 975052def4a02eeb3bd3e07e2d9606b9656a0e6dbc93699722b470c9dde6e1df},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41193807. Agents can read the archived copy with the MCP tool read_document.